Disorderly Brexit could put patients at risk, drug industry warns

LONDON (Reuters) - The supply of life-saving medicines in Europe could be severely disrupted unless Britain successfully negotiates a smooth and orderly exit from the EU, pharmaceutical industry leaders warned on Thursday.